Solid stock: buy or sell?
August 19th, 2019
Solid Biosciences, LLC engages in identifying and developing gene therapies for duchenne muscular dystrophy in the United States.
Should I buy Solid stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Solid Biosciences stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Solid stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 8 ratings published for SLDB stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-19||Svb Leerink||Market Perform||Outperform|
|2019-8-19||Leerink Swann||Market Perform||Outperform|
|2019-5-14||Goldman Sachs Group||Neutral||Sell|
|2019-5-14||Credit Suisse Group||Neutral||Underperform|
|2019-2-8||Svb Leerink||Outperform||Market Perform|
Solid stock analysis
After breaking up the SMA line of 100 days yesterday, Solid Biosciences closed at $9.30.
After breaking up the simple moving average line of 100d yesterday, Solid Biosciences closed today at $9.30, rocketed a 5.56%.
Solid shares skyrocketed 5.56% this week, ending at $9.30. By mid July SLDB plunged a bloodcurdling -11.55% in just one week.
Price pattern shows an uptrend with two rising tops and bottoms, and now finally trading above the $6.87 resistance.
Solid stock price history
Solid IPO was on January 26th, 2018 at $25.50 per share1. Since then, SLDB stock declined a -63.50%, with a yearly average of -63.50%.
1: Adjusted price after possible price splits or reverse-splits.
Solid stock historical price chart
SLDB stock reached 52-week highs on September at $54.54, and all-time highs 2018-06-19 with a price of 54.84.
Solid stock price target is $10.30Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we found 3 price predictions for SLDB stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-5-14||Credit Suisse Group||Downgrades||$7.00||$6.00||-14.3%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn March, Solid reported its latest financial data, posting a pretty good climb for the Earnings per Share (EPS). Experts expected $-0.58 per share, but Solid posted $-0.67.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn , Solid Biosciences annual revenues to million USD from marked in . , its income margin (compared to revenues) to , that is million.
Quarterly financial resultsReported quarter income marked $-21.92 million with a profit margin of . Profit margin remained constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Solid Biosciences sales marked a neutral movement and stayed steady a nan%. Looking back to recent quarterly results, Solid posted 5 positive quarters in a row.
Solid ownershipWhen you are planning to buy shares of a stock, it's worth to review its ownership structure.
Solid Biosciences shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 34.71% of all shares.
In case of Solid Biosciences stock, 77.40% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for SLDB stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Solid:
|Market cap||$329.3 M|
|Total shares||35.4 M|
|Float shares||3.6 M|
|- Institutional holdings (%)||77.4%|
|- Insider holdings (%)||34.7%|
|Shares in short selling||0.0%|
|Monday, August 19th, 2019|
|Day range||$9.03 - $10.48|
|Average true range||$0.93|
|50d mov avg||$5.47|
|100d mov avg||$6.74|
|200d mov avg||$14.31|
Solid performanceTo measure stock performance is always good to benchmark with competitors or related stocks. In the following table, we compare Solid Biosciences performance to :